Indegene's Q4 FY 2025-26 Quarterly Results

Result Summary

• Indegene Ltd reported a 5.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 29.8%.
• Its expenses for the quarter were up by 7.5% QoQ and 40.7% YoY.
• The net profit decreased 22.5% QoQ and decreased 32.2% YoY.
• The earnings per share (EPS) of Indegene Ltd stood at 3.3 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Indegene Ltd is a company operating within the healthcare and life sciences industry. It primarily focuses on providing healthcare solutions and services, which include business process outsourcing, healthcare analytics, and digital transformation solutions for life sciences companies. Indegene's services are aimed at enhancing the efficiency and effectiveness of healthcare organizations by leveraging data and technology. As of the data available until October 2023, there are no specific recent major developments noted for Indegene. This overview serves to provide a foundational understanding of the company's business model and the industry it operates in, though further specifics about recent strategic initiatives or expansions were not provided in the data.

Revenue

For Q4FY26, Indegene Ltd reported a total income of ₹1014.20 crores, up from ₹961.50 crores in Q3FY26, marking a quarter-over-quarter (QoQ) increase of 5.5%. Compared to Q4FY25, which reported a total income of ₹781.20 crores, the year-over-year (YoY) growth was 29.8%. These figures indicate that the company has experienced a significant increase in revenue both on a quarterly and yearly basis, reflecting strong performance in the latest quarter. However, specific drivers of this revenue increase, such as new contracts or expanded services, were not detailed in the data provided.

Profitability

The profitability metrics for Indegene Ltd show a decline despite the growth in revenue. The Profit Before Tax (PBT) for Q4FY26 was ₹105.10 crores, down from ₹134.70 crores in Q3FY26, representing a QoQ decrease of 22.0%. Compared to ₹149.30 crores in Q4FY25, the YoY decrease was 29.6%. The Profit After Tax (PAT) for Q4FY26 was ₹79.70 crores, down from ₹102.90 crores in Q3FY26, indicating a QoQ decline of 22.5%. The YoY comparison shows a decrease of 32.2% from ₹117.60 crores in Q4FY25. The Earnings Per Share (EPS) followed the same trend, declining from ₹4.26 in Q3FY26 to ₹3.30 in Q4FY26, and from ₹4.88 in Q4FY25, showing a QoQ and YoY decrease of 22.5% and 32.4%, respectively. These figures highlight that while the company has achieved revenue growth, its profitability has not followed the same trajectory.

Operating Metrics

Total expenses for Indegene Ltd in Q4FY26 were ₹888.80 crores, up from ₹826.80 crores in Q3FY26, representing a QoQ increase of 7.5%. When compared to Q4FY25, where total expenses were ₹631.90 crores, the YoY increase was 40.7%. This substantial rise in expenses over both periods indicates a trend of increasing operational costs. The tax expense for Q4FY26 was ₹25.40 crores, which is a decrease from ₹31.80 crores in Q3FY26, showing a QoQ reduction of 20.1%. When compared to Q4FY25, with a tax expense of ₹31.70 crores, the YoY decrease was 19.9%. These figures suggest that while Indegene Ltd has been managing its tax liabilities effectively, the overall increase in expenses has impacted its profitability metrics negatively.